Clinical and immunological study of Tofacitinib and Baricitinib in refractory Blau syndrome: case report and literature review

Blau syndrome (BS) is an autoinflammatory disorder characterized by non-caseating granulomatous dermatitis, arthritis, and uveitis. We present a case of refractory and severe BS that was treated with the Janus kinase inhibitors (JAKINIBS), Tofacitinib (TOFA) and then Baricitinib (BARI). Our aim was...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Carmen Álvarez-Reguera, Diana Prieto-Peña, Alba Herrero-Morant, Lara Sánchez-Bilbao, José Luis Martín-Varillas, Elena González-López, María Gutiérrez-Larrañaga, David San Segundo, Rosalía Demetrio-Pablo, Gonzalo Ocejo-Vinyals, Miguel A. González-Gay, Ricardo Blanco
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publishing 2022-04-01
Serija:Therapeutic Advances in Musculoskeletal Disease
Online pristup:https://doi.org/10.1177/1759720X221093211
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items